These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32881367)

  • 21. Epidemics will always come (and go): The need to prepare for the next one, research on COVID-19, and the role of molecular and cellular endocrinology.
    Stratakis CA; Laybutt DR; Laudet V; Klinge CM
    Mol Cell Endocrinol; 2020 Jul; 511():110863. PubMed ID: 32389799
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.
    Ovsyannikova IG; Haralambieva IH; Crooke SN; Poland GA; Kennedy RB
    Immunol Rev; 2020 Jul; 296(1):205-219. PubMed ID: 32658335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Found: genes that sway the course of the coronavirus.
    Kaiser J
    Science; 2020 Oct; 370(6514):275-276. PubMed ID: 33060342
    [No Abstract]   [Full Text] [Related]  

  • 24. Host genetic factors and susceptibility to SARS-CoV-2 infection.
    Schurr TG
    Am J Hum Biol; 2020 Sep; 32(5):e23497. PubMed ID: 32876373
    [No Abstract]   [Full Text] [Related]  

  • 25. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
    Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
    Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurological manifestations of COVID-19: available evidences and a new paradigm.
    Khatoon F; Prasad K; Kumar V
    J Neurovirol; 2020 Oct; 26(5):619-630. PubMed ID: 32839951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covid-19 infection and the host genetic predisposition: does it exist?
    Vašků A
    Physiol Res; 2020 Jul; 69(3):511-514. PubMed ID: 32682363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the BBMRI-ERIC Directory into a Global Catalogue of COVID-19-Ready Collections: A Joint Initiative of BBMRI-ERIC and ISBER.
    Catchpoole DR; Florindi F; Ahern C; Garcia DL; Mullins P; Van Enckevort E; Zaayenga A; Mayrhofer MT; Holub P
    Biopreserv Biobank; 2020 Oct; 18(5):479-480. PubMed ID: 32936006
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation.
    Ponsford MJ; Gkatzionis A; Walker VM; Grant AJ; Wootton RE; Moore LSP; Fatumo S; Mason AM; Zuber V; Willer C; Rasheed H; Brumpton B; Hveem K; Kristian Damås J; Davies N; Åsvold BO; Solligård E; Jones S; Burgess S; Rogne T; Gill D
    Circulation; 2020 Nov; 142(18):1791-1793. PubMed ID: 32966752
    [No Abstract]   [Full Text] [Related]  

  • 30. [Genetic and epigenetic variability, and the Covid-19 pandemic].
    Rivera-Silva G
    Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
    [No Abstract]   [Full Text] [Related]  

  • 31. Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
    Alonso DF; Farina HG
    Int J Antimicrob Agents; 2020 Sep; 56(3):106125. PubMed ID: 32739476
    [No Abstract]   [Full Text] [Related]  

  • 32. International Expansion of a Novel SARS-CoV-2 Mutant.
    Wang M; Li M; Ren R; Li L; Chen EQ; Li W; Ying B
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269121
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
    Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
    Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19.
    Saadat M
    Clin Chim Acta; 2020 Sep; 508():213-216. PubMed ID: 32454047
    [No Abstract]   [Full Text] [Related]  

  • 35. Virology, transmission, and pathogenesis of SARS-CoV-2.
    Cevik M; Kuppalli K; Kindrachuk J; Peiris M
    BMJ; 2020 Oct; 371():m3862. PubMed ID: 33097561
    [No Abstract]   [Full Text] [Related]  

  • 36. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
    Calender A; Israel-Biet D; Valeyre D; Pacheco Y
    Trends Immunol; 2020 Oct; 41(10):856-859. PubMed ID: 32863134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.
    Xie TA; Han MY; Su XR; Li HH; Chen JC; Guo XG
    J Cell Mol Med; 2020 Oct; 24(20):12225-12230. PubMed ID: 32924263
    [No Abstract]   [Full Text] [Related]  

  • 38. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?
    Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472
    [No Abstract]   [Full Text] [Related]  

  • 39. [What is the origin of SARS-CoV-2?].
    Torres-López J
    Rev Med Inst Mex Seguro Soc; 2020 Jan; 58(1):1-2. PubMed ID: 32412715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the molecular determinants of the SARS-CoV-2 attack.
    Kanduc D; Shoenfeld Y
    Clin Immunol; 2020 Jun; 215():108426. PubMed ID: 32311462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.